Time's up at high noon Eastern to respond to AS survey
By Howard Wolinsky
I have been nagging you for a month to respond to the survey several support groups and TheACtiveSurveillor.com are doing on issues impacting patients like those of us on active surveillance.
To join, click here: https://www.surveymonkey.com/r/W69XXDS
I won’t ask again.
But I will share a summary of results on such topics as what patients think about renaming Gleason 6 (Grade Group 1) as a noncancer, whether transperineal biopsies or transrectals should be the preferred method, and about how mental health issues impact the AS community.
The survey takes five to eight minutes and will be used to inform guideline writers, policymakers, clinicians, and researchers about the patient voice. We need to be heard and you can help.
Active Surveillance Patients International, AnCan Virtual Support Group for Active Surveillance, Prostate Cancer Support Canada, and The Active Surveillor newsletter are asking you to participate in a survey on patient attitudes toward Active Surveillance.
Time’s up.
Please help.
Moving AS to the next level
By Howard Wolinsky
There’s still time to register for an international webinar this Thursday, Nov. 17, on how participation in active surveillance can be increased.
The Active Surveillance Coalition, a collaboration of leading support groups for active surveillance (AS) for prostate cancer, is sponsoring a webinar at 9 a.m. Vancouver/12 p.m. New York/5 p.m. London/6 p.m. Amsterdam on Thursday, Nov. 17 to discuss how we can move the needle on AS, close monitoring of prostate cancer.
AS leaders from Sweden, Holland, the United Kingdom, and the state of Michigan’s will share their “secret sauce” for reaching AS rates of near 90% and above for low-risk patients,
The free webinar is entitled “Moving AS to the next level: Can we help more patients?”
Register here: https://bit.ly/ASnextlevel
The United States has lagged behind other wealthy countries in AS acceptance though the approach started here and in Canada in the late 1990s. AS uptake with AS finally reached a majority of 60% in 2021. The American Urological Association in 2022 set a new goal of 80% In 2010, only 6% of patients qualified for AS opted for this approach.
Several European countries and the state of Michigan’s MUSIC (Michigan Urological Surgery Improvement Collaborative) program have reached AS uptakes of around 90% or higher.
Panel members will present their stories followed by a discussion and a Q&A involving the audience.